We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Vij - Final Results From the Bortezomib-naïve Group of PX-171-004, a Phase 2 Study of Single-Agent Carfilzomib in Patients with Relapsed and/or Refractory MM
Ravi Vij, MD
Washington University School of Medicine
Saint Louis, Missouri, USA
12.07.11

Be the first to comment

 related articles